2018•Digestive and Liver DiseaseRequires access

A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis

Sara Renna, Filippo Mocciaro, Marco Ventimiglia, Rosalba Orlando, Fabio Salvatore Macaluso, Maria Cappello, Walter Fries, Marco Mendolaro, Antonino Carlo Privitera, Concetta Ferracane, V Pisana, Antonio Magnano, Dario Pluchino, Gaetano Inserra, G. Scarpulla, Serena Garufi, Antonio Carroccio, Sebastiano Siringo, Roberto Di Mitri, Mario Cottone, Ambrogio Orlando

Open publisher page 20 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Golimumab, Adalimumab, Medicine, Ulcerative colitis, Internal medicine, Propensity score matching, Gastroenterology, Disease